Literature DB >> 24183203

The advance of application for microRNAs in cancer gene therapy.

Guanghua Yang1, Baobing Yin2.   

Abstract

MicroRNAs (miRNAs, miRs) are closely associated with biological processes of tumor cells as the key regulators by recognizing specific mRNA targets, and further mediating post-transcriptional inhibition of tumor related genes. Therefore, miRNAs may be used as optional therapeutic targets in tumors resulting from accumulation of multiple gene mutations and their interactions. Currently, there are many researches for making miRNAs safely and efficiently be applied in cancer gene therapy (CGT). This review summarizes miRNA anomalous biogenesis pathway, different roles in disease processes of tumors, by which it further clarifies miRNA implemented methods including the combined treatment related with miRNA in CGT; simultaneously, briefly illustrates the delivery systems of miRNA.
Copyright © 2013 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Gene therapy; Liposome; MicroRNA; Tumor

Mesh:

Substances:

Year:  2013        PMID: 24183203     DOI: 10.1016/j.biopha.2013.10.002

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  8 in total

1.  Shiga-like toxin I exerts specific and potent anti-tumour efficacy against gastric cancer cell proliferation when driven by tumour-preferential Frizzled-7 promoter.

Authors:  Hongpan Xu; Lijun Peng; Mengjiao Shen; Yanyan Xia; Zhiyang Li; Nongyue He
Journal:  Cell Prolif       Date:  2019-04-06       Impact factor: 6.831

2.  Effect of microRNA-1 on hepatocellular carcinoma tumor endothelial cells.

Authors:  Chao Hu; Shi-Qiang Shen; Zhong-Hui Cui; Zu-Bing Chen; Wei Li
Journal:  World J Gastroenterol       Date:  2015-05-21       Impact factor: 5.742

3.  The miR-429 suppresses proliferation and migration in glioblastoma cells and induces cell-cycle arrest and apoptosis via modulating several target genes of ERBB signaling pathway.

Authors:  Fatemeh Gheidari; Ehsan Arefian; Fatemeh Saadatpour; Mahboubeh Kabiri; Ehsan Seyedjafari; Ladan Teimoori-Toolabi; Masoud Soleimani
Journal:  Mol Biol Rep       Date:  2022-10-11       Impact factor: 2.742

4.  MicroRNA-4530 promotes angiogenesis by targeting VASH1 in breast carcinoma cells.

Authors:  Tao Zhang; Li Jing; Hong Li; Linchao Ding; Dongdong Ai; Jianxin Lyu; Lianjin Zhong
Journal:  Oncol Lett       Date:  2017-04-28       Impact factor: 2.967

5.  Pattern of cell-to-cell transfer of microRNA by gap junction and its effect on the proliferation of glioma cells.

Authors:  Yuexia Peng; Xiyan Wang; Yunquan Guo; Fuhua Peng; Ningze Zheng; Bo He; Hui Ge; Liang Tao; Qin Wang
Journal:  Cancer Sci       Date:  2019-06       Impact factor: 6.716

6.  The protective effects of the miR-129-5p/keap-1/Nrf2 axis on Ang II-induced cardiomyocyte hypertrophy.

Authors:  Huiming Ye; Guiyu Xu; Dexian Zhang; Rupeng Wang
Journal:  Ann Transl Med       Date:  2021-01

7.  The miR-142 Suppresses U-87 Glioblastoma Cell Growth by Targeting EGFR Oncogenic Signaling Pathway.

Authors:  Fatemeh Gheidari; Ehsan Arefian; Fatemeh Jamshidi Adegani; Fereshteh Fallah Atanaki; Masoud Soleimani
Journal:  Iran J Pharm Res       Date:  2021       Impact factor: 1.696

8.  MicroRNA-138 functions as a tumor suppressor in osteosarcoma by targeting differentiated embryonic chondrocyte gene 2.

Authors:  Baoen Jiang; Weidong Mu; Jiangquan Wang; Jianshu Lu; Shanyong Jiang; Liang Li; Haining Xu; Hongyan Tian
Journal:  J Exp Clin Cancer Res       Date:  2016-04-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.